Dr. Charles Wynter Callender, MD

Dr. Callender practices at Southeast Georgia Health System-Brunswick Campus in Brunswick, Georgia, part of Southeast Georgia Health System.

Dr. Callender's NPI, 1972576320, was assigned on February 8, 2006. Dr. Callender graduated from VCU School of Medicine in 1995. Dr. Callender holds Georgia license 069156.

Dr. Callender's primary practice is Southeast Georgia Health System-Brunswick Campus, at 2415 Parkwood Drive, Brunswick, GA 31520 in Glynn County. The practice phone is (912) 466-7000.

Dr. Callender's primary practice is Southeast Georgia Health System-Brunswick Campus in Brunswick, Georgia, part of Southeast Georgia Health System. Dr. Callender is also affiliated with Atrium Health Navicent The Medical Center. The medical group on file is Southeast Georgia Physician Associates. Dmand AI also links Dr. Callender to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callender practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Callender's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Callender is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Callender's licenses on file in 5 states: Georgia, Nebraska, Virginia, Tennessee and Michigan.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, lung disease: COPD, asthma or bronchitis and pleural effusion among the conditions Dr. Callender treats.

CMS data shows 1,343 Medicare services from Dr. Callender across 15 procedure codes in 2024, for 445 Medicare patients. Medicare paid $117,092 for them.

CMS counts 445 Medicare patients who saw Dr. Callender in 2024. The largest group is 65 to 74, with 184 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Callender's median patient age at 73, with 59% women.

In 2024, Dr. Callender wrote 1,292 Medicare Part D claims for 270 patients. CMS names the drug for 1,162 of them, across 27 drugs with 11 or more claims each, at $815,584 in total drug cost. In 2023, CMS named 842 claims across 20 drugs.

Dr. Callender accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Callender. Dr. Callender's most frequent co-authors are Aftab Ahmed, MD, Amy Bourgeois Christie, MD and Erskine A. James, MD.

Dmand AI links Dr. Callender to 1 clinical trial. Conditions studied include Venous Thromboembolism and Thromboembolism.

CMS Open Payments shows 691 general payments to Dr. Callender from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Sanofi and Genzyme US Companies paid the most, $4,553.

Dmand AI lists 2 awards for Dr. Callender, most recently CMS Stage 1 EHR in 2012.

Dr. Callender graduated from VCU School of Medicine in 1995.

Dr. Callender is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.